The final thesis of Professor Lim Soo's team of the Department of Endocrine Metabolism at Bundang Seoul National University Hospital was published in the world-renowned journal Nature Review (IF 40.4) ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...

The early stages of chronic kidney disease (CKD) are usually asymptomatic, with kidney function progressively and ...

In the phase 2 MIRO-CKD trial, investigators tested a novel MRA in combination with an SGLT2 inhibitor and included patients with higher serum potassium levels than 4.8 mmol/L at baseline and patients ...

An open-label study shows that patients who took metformin after catheter ablation for atrial fibrillation have significantly ...

HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...

Type 2 Diabetes is not just a disorder of glucose regulation but a visible marker of deep-seated metabolic chaos. By ...

A real-world analysis published in JACC Advances concludes that heart failure patients prescribed ivabradine face a significantly higher risk of developing atrial fibrillation (AF) within 180 ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, ...

The world celebrates World Diabetes Day on Nov. 14 each year, with the aim of raising global awareness to combat the disease and its complications, as well as focusing on ways ...